Literature DB >> 11797961

Sector analysis of prostate implants.

W S Bice1, B R Prestidge, M F Sarosdy.   

Abstract

The analysis of treatment plans generated following prostate implants (post plans) is an essential part of the patient's treatment regimen. The results are used to determine the adequacy of the individual implant and, just as importantly, to provide an evaluation of the institution's brachytherapy technique. Compiled post plan results can be used to compare data from different institutions and help determine guidelines that should be established as dosimetric goals. Sector analysis, or spatial dose mapping, is a novel method of analyzing brachytherapy results that has been developed for this purpose. The display of isodose curves provides spatial information pertaining to the dosimetric evaluation of post plans but is an unwieldy tool; ill suited to the creation of general conclusions for comparative efforts. Dose-volume histogram (DVH) analysis is an excellent tool for examining dosimetric results, but the spatial information is lost. Sector analysis bridges the gap between isodose curves and DVH analysis in post plan analysis. To perform sector analysis we divide the gland into three regions in the cranial-caudal direction (base, midgland, and apex) and four regions on each transverse slice (anterior, posterior, left and right). This gives twelve sectors, each identified by its location in the cranial-caudal direction and position on the transverse slice, e.g., posterior midgland. DVH analysis is performed for each region separately and compiled for display. We present an example of the use of this technique wherein we have analyzed a sequential series of 118 implants performed by a single practitioner (BRP) at two institutions over a calendar year. The implants were performed using two different techniques at the two institutions. Sector analysis was used to compare the results of the implants at the two institutions.

Entities:  

Mesh:

Year:  2001        PMID: 11797961     DOI: 10.1118/1.1418016

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  4 in total

1.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

2.  Evaluation of transrectal ultrasound-based dosimetry for brachytherapy of prostate cancer: a single-center experience.

Authors:  Changzhao Yang; Zhengtong Lv; Lingxiao Chen; Jie Wang; Xiheng Hu; Harripersaud Chand; Xi Sun; Guyu Tang; Congyi Tang; Huichuan Jiang; Yuan Li
Journal:  J Contemp Brachytherapy       Date:  2020-08-21

3.  Comparison of implant quality between intraoperatively built custom-linked seeds and loose seeds in permanent prostate brachytherapy using sector analysis.

Authors:  Norihisa Katayama; Mitsuhiro Takemoto; Atsushi Takamoto; Hiroki Ihara; Kuniaki Katsui; Shin Ebara; Yasutomo Nasu; Susumu Kanazawa
Journal:  J Radiat Res       Date:  2016-03-13       Impact factor: 2.724

4.  Correlations of post-implant regional dosimetric parameters at 24 hours and one month, with clinical results of low-dose-rate brachytherapy for localized prostate cancer.

Authors:  Eiichiro Okazaki; Katsuyuki Kuratsukuri; Kentaro Ishii; Tomoaki Tanaka; Ryo Ogino; Tomohiro Nishikawa; Hideyuki Morimoto; Masako Hosono; Yukio Miki
Journal:  J Contemp Brachytherapy       Date:  2017-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.